RXRX - Recursion Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RXRX is currently covered by 6 analysts with an average price target of $11.65. This is a potential upside of $5.38 (85.81%) from yesterday's end of day stock price of $6.27.

Recursion Pharmaceuticals's activity chart (see below) currently has 20 price targets and 44 ratings on display. The stock rating distribution of RXRX is 20% HOLD and 80% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60% with an average time for these price targets to be met of 48.43 days.

Highest price target for RXRX is $12, Lowest price target is $8, average price target is $11.65.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 07-Nov-2024. First documented stock forecast 11-May-2021.

Best performing analysts who are covering RXRX - Recursion Pharmaceuticals:

Gil Blum Eric Joseph Michael Ryskin Scott Schoenhaus Salveen Richter Mani Foroohar Gal Munda

Currently out of the existing stock ratings of RXRX, 5 are a HOLD (20%), 20 are a BUY (80%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$4.82 (77.99%)

$11

13 days ago
(07-Nov-2024)

2/15 (13.33%)

$4.07 (58.73%)

71

Hold

$8

$1.82 (29.45%)

$8

2 months 17 days ago
(03-Sep-2024)

4/6 (66.67%)

$1.93 (31.80%)

63

Buy

$12

$5.82 (94.17%)

$16

4 months 9 days ago
(11-Jul-2024)

2/5 (40%)

$4.32 (56.25%)

35

Hold

$10

$3.82 (61.81%)

$32

1 years 7 days ago
(13-Nov-2023)

2/2 (100%)

$4.17 (71.53%)

35

Buy

$33

$26.82 (433.98%)

$38

1 years 4 months 8 days ago
(12-Jul-2023)

0/3 (0%)

$20.92 (173.18%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?

On average it took 48.43 days on average for the stock forecasts to be realized with a an average price target met ratio 60

Which analyst has the current highest performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GIL BLUM

Which analyst has the current lower performing score on RXRX (Recursion Pharmaceuticals) with a proven track record?

GAL MUNDA

Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?

Gil Blum works at NEEDHAM and has 24 price targets and 21 ratings on RXRX

Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?

Gal Munda with highest potential upside - $26.82

Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?

Mani Foroohar with lowest potential downside - $1.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?